Trademark: 88229766
Word
INTERMOUNTAIN GENETARGET
Status Date
Monday, January 27, 2020
Filing Date
Friday, December 14, 2018
Published for Opposition
Tuesday, April 30, 2019
Abandoned Date
Monday, January 27, 2020
44 Medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; and providing an online searchable database in the fields of oncology, bioinformatics, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer
"GENE TARGET"
INTER MOUNTAIN GENE TARGET
as to "INTERMOUNTAIN"
Jan 27, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 27, 2020
Abandonment - No Use Statement Filed
Jun 25, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 30, 2019
Published For Opposition
Apr 10, 2019
Notification Of Notice Of Publication E-Mailed
Mar 20, 2019
Approved For Pub - Principal Register
Mar 13, 2019
Assigned To Examiner
Jan 7, 2019
New Application Office Supplied Data Entered In Tram
Dec 18, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
